drugset
drugset / Trial / NCT00791388

Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days

NCT00791388 ↗

Phase 1 Completed 45 enrolled Procter and Gamble
RandomizedParallel-groupDouble-blind

Summary

This study is a multiple ascending dose study to Assess the Safety, Tolerability, and Pharmacokinetics of orally dosed PG 760564 Administered Twice Daily to Healthy Male and Female Volunteers for 14 Days (27 Doses).

Timeline

Start
2005-08
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject PG-760564 Unknown 50 mg Oral
Subject PG-760564 Unknown 100 mg Oral
Subject PG-760564 Unknown 200 mg Oral
Subject PG-760564 Unknown 400 mg Oral

Indications

No indication recorded.